Keywords: fda, clears, nutropin, aq, pen, food, drug
FDA clears Nutropin AQ Pen
Article | 29 April 2002
The US Food and Drug Administration has cleared Genentech's NutropinAQ Pen (somatropin [rDNA origin] injection), for long-term treatment of growth ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
